Federal Register / Vol. 73, No. 183 / Friday, September 19, 2008 / Notices 54405 

EXHIBIT 3. ANNUAL COSTS FOR THE ESTIMATE OF THE NUMBER OF PERSONS WHO CAN ACCESS THEIR MEDICATION

INFORMATION ONLINE—Continued 

Annual cost 

Interviewer training, sample purchase, survey administration, data entry, toll calls ................................................................... 30,274 

Other direct costs: 

Computer charge, telephone/fax/teleconference, printing and duplication, travel ....................................................................... 28,418 

Indirect costs: 

Regular overhead, 46.5%; G&A ................................................................................................................................................... 101,775 

Contract Fee ........................................................................................................................................................................................ 25,602 

Total .............................................................................................................................................................................................. $310,067 

Request for Comments 

In accordance with the above-cited 

Paperwork Reduction Act legislation, 

comments on AHRQ’s information 

collection are requested with regard to 

any of the following: (a) Whether the 

proposed collection of information is 

necessary for the proper performance of 

AHRQ health care research, quality 

improvement and information 

dissemination functions, including 

whether the information will have 

practical utility; (b) the accuracy of 

AHRQ’s estimate of burden (including 

hours and costs) of the proposed 

collection(s) of information; (c) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(d) ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: September 9, 2008. 

Carolyn M. Clancy, 

Director. 

[FR Doc. E8–21824 Filed 9–18–08; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–8003] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare & Medicaid 

Services (CMS), Department of Health 

and Human Services, is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the Agency’s function; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Home and 

Community Based Waiver Requests and 

Supporting Regulations in 42 CFR 

440.180 and 441.300–310; Use: Under a 

Secretarial waiver, States may offer a 

wide array of home and communitybased services to individuals who 

would otherwise require 

institutionalization. States requesting a 

waiver must provide certain assurances, 

documentation and cost and utilization 

estimates which are reviewed, approved 

and maintained for the purpose of 

identifying/verifying States’ compliance 

with such statutory and regulatory 

requirements. Form Number: CMS–8003 

(OMB# 0938–0449); Frequency: 

Occasionally; Affected Public: State, 

Local or Tribal Governments; Number of 

Respondents: 50; Total Annual 

Responses: 136; Total Annual Hours: 

8,010. 

To obtain copies of the supporting 

statement and any related forms for the 

proposed paperwork collections 

referenced above, access CMS Web Site 

address at http://www.cms.hhs.gov/ 

PaperworkReductionActof1995, or email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov, or call the 

Reports Clearance Office on (410) 786– 

1326. 

To be assured consideration, 

comments and recommendations for the 

proposed information collections must 

be received by the OMB desk officer at 

the address below, no later than 5 p.m. 

on October 20, 2008. 

OMB, Office of Information and 

Regulatory Affairs, Attention: CMS 

Desk Officer, New Executive Office 

Building, Room 10235, Washington, 

DC 20503, Fax Number: (202) 395– 

6974. 

Dated: September 11, 2008. 

Michelle Shortt, 

Director, Regulations Development Group. 

Office of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. E8–21906 Filed 9–18–08; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2008–N–0038] 

Structured Product Labeling Content 

of Labeling and Electronic Drug 

Establishment Registration and Drug 

Listing for the Biologics Industry; 

Public Workshop 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of public workshop. 

The Food and Drug Administration 

(FDA) is announcing a public workshop 

entitled ‘‘Structured Product Labeling 

(SPL) Content of Labeling and 

Electronic Drug Establishment 

Registration and Drug Listing for the 

Biologics Industry.’’ The purpose of the 

public workshop is to provide the 

biologics industry with guidance on 

submitting to FDA content of labeling in 

SPL format, present an overview of 

FDA’s voluntary pilot program for 

electronic submission of drug 

establishment registration and drug 


jlentini on PROD1PC65 with NOTICES